Top topics

Pharmaceutical companies

Now playing Next

AstraZeneca reports strong results boosted by promising trials

ADVERTISEMENT

ADVERTISEMENT

Top topics

More about this topic

Now playing Next

Bayer shares fall as pharma giant’s results fail to cheer investors

Bayer’s share price fell on Tuesday, following the company releasing lacklustre third quarter earnings with a warning that the current challenges may also impact next year’s results as well.

12/11/2024

Now playing Next

AstraZeneca beats expectations and raises guidance despite China woes

AstraZeneca raises its fiscal 2024 guidance for the second consecutive quarter. This upgrade comes despite ongoing legal challenges in China as it reported robust third-quarter earnings results.

12/11/2024

Now playing Next

CVC Capital Partners seeks cash injection for Italian pharma group

The private equity business is reported to be looking for a buyer to take on its majority stake in Genetic Group, an Italian pharmaceutical contract manufacturing company.

11/11/2024

Now playing Next

European Commission fines MS drug maker Teva over improper patent use

The European Commission says it has fined the Israeli generic drug maker, Teva, more than €460m for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company's development of a competing medicine.

31/10/2024

ADVERTISEMENT

Now playing Next

Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R

The American private equity firm has agreed to French government demands about protecting jobs and investment in France.

21/10/2024

Now playing Next

Sanofi unit bid: Group raises offer, pledging to save French jobs

The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the maker of France's best-selling drug.

17/10/2024

Now playing Next

Surging drug costs straining national budgets, health insurers warn

Rising pharmaceutical prices, particularly for novel therapies and cancer treatments, are driving increased health spending across Europe, placing significant strain on national budgets, according to a new study published this week.

16/10/2024

Now playing Next

French minister says block to Sanofi deal is still 'on the table'

The potential sale of Opella, which produces Doliprane painkillers, is causing a headache in France.

16/10/2024

Now playing Next

US private equity firm set to win Sanofi's consumer health division

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes over-the-counter medicine such as Doliprane and Allegra.

11/10/2024

Now playing Next

GSK shares leap after drug firm settles US Zantac cancer claim lawsuit

GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies were not reliable.

10/10/2024

Now playing Next

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.

17/09/2024

Now playing Next

Bavarian Nordic shares rise on stronger earnings and major Mpox order

The company recently received a 440,000 smallpox and Mpox vaccine dose contract from an unnamed European country.

22/08/2024

Now playing Next

Possible drug shortages in Germany as China tightens espionage laws

Several German states have suspended trips by their quality-control inspectors to Chinese pharmaceutical companies over tightened espionage laws.

19/08/2024

Now playing Next

Vaccine makers see share prices spike as concerns grow over Mpox

The share prices of a number of healthcare and pharmaceutical companies worldwide rose on Friday as the World Health Organisation (WHO) declared a rapidly-spreading African Mpox outbreak a public health emergency.

16/08/2024

Now playing Next

Bayer stock soars as German pharma company wins Roundup legal battle

Shares in German pharmaceutical and biotechnology company Bayer climbed nearly 13% on Friday after the company won a legal battle in the US related to its Roundup weedkiller.

16/08/2024

Now playing Next

AstraZeneca leads in valuation as it bets on cancer drugs portfolio

The company has tied up with Eccogene, a Chinese biotech firm, for a new experimental weight loss drug. The weight loss market is currently dominated by Eli Lilly and Novo Nordisk.

14/08/2024

Now playing Next

French-born boss of AstraZeneca named highest-paid CEO in Britain

Pascal Soriot headed a list of top earners compiled by the High Pay Centre, with bosses of Rolls Royce and HSBC also included in the top 10.

12/08/2024

Now playing Next

Novo Nordisk: Earnings trimmed as rivals seek to enter market

Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024.

07/08/2024

Now playing Next

Bayer reaps benefits of demand for new cancer and kidney medicines

German pharmaceutical giant Bayer AG released its second quarter and half year 2024 earnings on Tuesday morning, with the company seeing an average performance in the second quarter, due to the agricultural market environment becoming tougher.

06/08/2024

Now playing Next

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

30/07/2024